As C/EBP transcription factors transduce the signals of numerous pro-atherogenic stimuli, pharmacological targeting of C/EBP activity and/or expression could be a novel strategy to counteract oxidative stress by modulating Nox and to improve vascular functions in vascular inflammatory disorders such as atherosclerosis. Here, CEBPA is linked to atherosclerosis.